Interestingly, our results are consistent with a study from Poggi et al. [44], which shows that lack of the inhibitory receptor LAIR-1 (leukocyte-associated Ig-like receptor 1) is associated with high-risk CLL. The gene discussed is LAIR1; the disease is B-cell chronic lymphocytic leukemia.